Outcome | |||||||
---|---|---|---|---|---|---|---|
ACG | IM | LGD | HGD/Ca | Total | |||
Type I | Type II | Type III | |||||
ACG, atrophic chronic gastritis; IM, intestinal metaplasia; LGD, low grade dysplasia; HGD/Ca, lesions as severe as high grade dysplasia or high grade non-invasive neoplasia. | |||||||
First biopsy | |||||||
ACG | 33 (57%) | 6 (10%) | 12 (21%) | 7 (12%) | 58 | ||
IM | |||||||
Type I | 8 (13%) | 24 (39%) | 25 (41%) | 5 (8%) | 62 | ||
Type II | 7 (15%) | 13 (27%) | 13 (27%) | 14 (29%) | 1 (2%) | 48 | |
Type III | 1 (10%) | 2 (20%) | 4 (40%) | 3 (30%) | 10 | ||
LGD | 13 (21%) | 15 (24%) | 13 (21%) | 1 (2%) | 13 (21%) | 7 (11%) | 62 |
Total | 60 | 58 | 64 | 3 | 43 | 11 | 239 |